Adverse dose-dependent effects of morphine therapy in acute heart failure. (15th October 2019)

• Record Type: Journal Article
• Authors: Caspi, Oren; Naami, Robert; Halfin, Elya; Aronson, Doron
• Is Part Of: International journal of cardiology. Volume 293(2019)
• Page Start: 131
• Page End: 136
• Publication Date: 2019-10-15
• Subjects: Heart failure -- Opiates -- Mechanical ventilation; Cardiology -- Periodicals; Electronic journals; 616.12
• DOI: 10.1016/j.ijcard.2019.06.015
• Languages: English
• ISSNs: 0167-5273

Abstract

Abstract: Background: Morphine has been a pivotal therapy in acute heart failure (AHF) for more than a century. The evidence for morphine therapy in AHF remains controversial. This study sought to assess the therapeutic effect of morphine on patients with AHF. Methods: The study used a cohort of 13, 788 patients admitted with a primary diagnosis of AHF. Propensity-score-matching was generated using 26 clinical variables. Primary endpoints included in-hospital mortality and invasive mechanical ventilation. Secondary endpoints included non-invasive ventilation, need for inotropes and acute kidney injury (AKI). Results: 761 (5.5%) patients were treated with morphine in the first day following hospital admission. Propensity score matching yielded 672 patient pairs. The incidence of invasive ventilation was higher in the morphine-treated patients (7.4%) than in matched patients in the no-morphine cohort (3.6%), OR 2.13 (95% CI 1.32–3.57, P = 0.007). In-hospital mortality was also higher in the morphine group (17.4%) than in the matched no-morphine group (13.4%), OR 1.43 (95% CI 1.05 to 1.98, P = 0.024). For both the endpoint of invasive ventilation ( P trend = 0.005) and mortality ( P trend = 0.004), there was a significant linear dose-response relationship for the adverse effect of morphine. Morphine was associated with a significant increase in all secondary outcomes: Non-invasive ventilation (OR 2.78, 95% CI 1.95–3.96); Inotrope use (OR 3.50, 95% CI 2.10–5.82) and AKI (OR 1.81, 95% CI 1.39–2.36). A landmark analysis demonstrated no difference in post-discharge survival between cohorts. Conclusions: Morphine administration is associated with significant dose-dependent risk for in-hospital mortality and need for mechanical ventilation. Highlights: Recent studies raised concerns regarding the safety of morphine therapy in AHF. We studied 672 pairs of morphine-treated and propensity score matched controls. Morphine was associated with higher risks for ventilation and in-hospital mortality. A dose-dependent effect of morphine on the primary endpoints was identified. Future studies should explore potential alternatives to morphine in AHF.